DAFNA Capital Management’s Denali Therapeutics DNLI Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2025
Q2
$2.36M Buy
168,500
+40,600
+32% +$568K 0.65% 35
2025
Q1
$1.74M Buy
+127,900
New +$1.74M 0.49% 41